Gainers

  • ARS Pharmaceuticals SPRY shares increased by 79.4% to $8.11 during Friday's regular session. ARS Pharmaceuticals's stock is trading at a volume of 50.1 million shares as of 13:30 EST. This is 16117.0% of its average full-day volume over the last 100 days. The company's market cap stands at $766.1 million.
  • AirSculpt Technologies AIRS stock rose 40.49% to $6.87. Trading volume for AirSculpt Technologies's stock is 1.0 million as of 13:30 EST. This is 432.4% of its average full-day volume over the last 100 days. The company's market cap stands at $389.6 million. The company's, Q1 earnings came out today.
  • Dermata Therapeutics DRMA shares moved upwards by 32.12% to $2.55. Dermata Therapeutics's stock is trading at a volume of 36.1 million shares as of 13:30 EST. This is 1443.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.1 million. The company's, Q1 earnings came out yesterday.
  • Apyx Medical APYX stock moved upwards by 22.09% to $5.47. The current volume of 1.1 million shares is 747.1% of Apyx Medical's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $189.2 million. As per the press release, Q1 earnings came out yesterday.
  • VYNE Therapeutics VYNE stock moved upwards by 17.83% to $7.19. The current volume of 107.2K shares is 14.9% of VYNE Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $23.4 million. As per the news, the Q1 earnings report came out yesterday.
  • Meihua Intl Medical Techs MHUA stock increased by 14.37% to $3.5. Meihua Intl Medical Techs's stock is trading at a volume of 1.3 million shares as of 13:30 EST. This is 1976.1% of its average full-day volume over the last 100 days. The company's market cap stands at $83.7 million.

Losers

  • Assure Hldgs IONM stock fell 38.4% to $1.19 during Friday's regular session. Trading volume for Assure Hldgs's stock is 2.8 million as of 13:30 EST. This is 723.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.3 million. The company's, Q1 earnings came out 2 days ago.
  • Heron Therapeutics HRTX shares fell 37.9% to $1.39. The current volume of 10.8 million shares is 531.7% of Heron Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $165.2 million. As per the press release, Q1 earnings came out yesterday.
  • Impel Pharmaceuticals IMPL shares fell 33.61% to $1.51. Trading volume for Impel Pharmaceuticals's stock is 109.6K as of 13:30 EST. This is 227.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $35.9 million. As per the press release, Q1 earnings came out today.
  • ViewRay VRAY shares fell 28.01% to $0.6. Trading volume for this security as of 13:30 EST is 5.8 million, which is 265.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $109.3 million. As per the news, the Q1 earnings report came out 2 days ago.
  • Xenetic Biosciences XBIO shares decreased by 27.53% to $0.29. Trading volume for Xenetic Biosciences's stock is 443.0K as of 13:30 EST. This is 1347.5% of its average full-day volume over the last 100 days. The company's market cap stands at $4.3 million. As per the news, the Q1 earnings report came out yesterday.
  • Aquestive Therapeutics AQST stock decreased by 26.91% to $1.82. Trading volume for this security as of 13:30 EST is 2.0 million, which is 497.5% of its average full-day volume over the last 100 days. The company's market cap stands at $101.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!